Broadly reactive antibodies against a gp120 V3 loop multi-epitope polypeptide neutralize different isolates of human immunodeficiency virus type 1 (HIV-1)

Vaccine

Volumn 15, Issue 11, 1997, Pages 1200-1208

  Montero, Marinieve ^a   Menéndez, Alfredo ^a   Domínguez, María Del Carmen ^a   Navea, Leonor ^b   Vilarubia, Olga Lidia ^b   Quintana, Diógenes ^a   Izquierdo, Marisela ^b   Jiménez, Victor ^a   Reyes, Osvaldo ^a   Lobaina, Leonor ^b   Noa, Enrique ^b   Duarte, Carlos A ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^b National Reference Center for AIDS   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; FREUND ADJUVANT; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; MULTI EPITOPE POLYPEPTIDE TAB 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOGENICITY; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RABBIT; VIRUS NEUTRALIZATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; CONSENSUS SEQUENCE; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HIV ANTIBODIES; HIV ANTIGENS; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; RABBITS;

EID: 0343742575     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00012-1     Document Type: Article

References (55)

1. Chiou, S.H., Freed, E.O., Paganiban, A.T. and Keneally, W.R. Studies on the role of the V3 region in Human Immunodeficiency virus type 1 envelope glycoprotein function. AIDS Research on Human Retroviruses 1992, 8, 1611-1617.
2. Ivanoff, L., Looney, D.J., McDanal, C., Morris, J.F., Wong-Staal, F., Langlois, A.J., Petteway, S.R. Jr. and Matthews, T.J. Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain. AIDS Research on Human Retroviruses 1991, 7, 595-603.
3. Shioda, T., Levy, J.A. and Chen-Mayer, C. Macrophage and T-cell line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature 1991, 349, 167-169.
4. Palker, T.J., Clark, M., Langloise, A.J., Mathews, T.J., Weinhold, K.J., Randall, R.R., Bolognesi, D. and Haynes, B.F. Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proceedings of the National Academy of Sciences of the United States of America 1988, 85, 1932-1936.
5. Rushe, J.R., Jahaverian, K., McDanal, C., Petro, J., Lynn, D.L., Grimaila, R., Langlois, A., Gallo, R.C., Arthur, L.O., Fischinger, P.J., Bolognesi, D.P., Putney, S.D. and Mathews, T.J. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-aminoacid sequence of viral envelope gp120. Proceedings of the National Academy of Sciences of the United States of America 1988, 85, 3192-3202.
6. Goudsmit, J., Boucher, C.A., Meloen, R.H., Epstein, L.G., Smit, L., van der Hoek, L. and Bakker, M. Human antibody response to a strain-specific HIV-1 gp120 epitope associated with cell fusion inhibition. AIDS 1988, 2, 157-164.
7. Kennealy, W.R., Matthews, T.J., Ganfield, M.C., Langlois, A.J., Waselefsky, D.M. and Petteway, S.R. Jr Antibodies from Human Immunodeficiency Virus-infected individuals bind to a short amino acid sequence that elicits neutralizing antibodies in animals. AIDS Research on Human Retroviruses 1989, 5, 173-182.
8. Jahaverian, K., Langlois, A.J., McDanal, C., Ross, K.L., Eckler, L.I., Cindy, L., Jellis, L., Profy, A.T., Rusche, J.R., Bolognesi, D.P., Putney, S.D. and Mathews, T.J. Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proceedings of the National Academy of Sciences of the United States of America 1989, 86, 6768-6772.
9. Putney, S., Javaherian, K., Profy, A., Emini, E., Langlois, A., Ross, K., et al. In Human Retroviruses. Alan R. Liss, 1990, pp. 323-335.
10. Takahashi, H., Cohen, J., Hosmalin, A., Cease, K.B., Houghten, R., Cornette, J.L., et al. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp16O recognized by class I major histocompatibility complex molecule-restricted immune cytotoxic T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 1988, 85, 3105.
11. Lasarte, J.J., Sarobe, P., Gullón, A., Prieto, J. and Borrás-Cuesta, F. Induction of cytotoxic T lymphocytes in mice against the principal neutralizing domain of HIV-1 by immunization with an engineered T-cytotoxic-T-helper synthetic peptide construct. Cellular Immunology 1992, 141, 211-218.
12. Takahashi, H., Nakagawa, Y., Pendleton, C., Hougten, R., Yokomuro, K., Germaine, R.N. and Berzofsky, J.A. Induction of broadly cross-reactive T cells recognizing an HIV-1 envelope determinant. Science 1992, 255, 333-336.
13. Moore, R.L. and Fox, B.S. Immunization of mice with human immunodeficiency virus glycoprotein gp160 peptide 315-329 induce both class I and class II restricted T-cells: Not all cells can respond to whole molecule stimulation. AIDS Research on Human Retroviruses 1993, 9, 51-59.
14. Takahashi, H., Germaine, R.N., Moss, B. and Berzofsky, J.A. An immunodominant class I-restricted cytotoxic T lymphocytes determinant on human immunodeficiency virus type 1 induces CD 4 class II-restricted help for itself. Journal of Experimental Medicine 1990, 171, 571-576.
15. Billaud, J.N., Yagello, M. and Gluckman, J.C. Primary in vitro sensitization of human T-helper lymphocytes by peptides derived from the V3 loop of human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein. Vaccine 1994, 12, 46-55.
16. Safrit, J.T., Fung, M.S.C., Andrews, C.A., Braun, D.G., Sun, W.N.C., Chang, T.W. and Koup, R.A. hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120. AIDS 1993, 7, 15-21.
17. Emini, E., Schleif, W.A., Numberg, J.H., Conley, A.J., Eda, Y., Tokiyoshi, S., Putney, S.D., Matsushita, S., Cobb, K.E., Jett, C., Eichberg, J. and Murthy, K. Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain specific monoclonal antibody. Nature 1992, 355, 728-730.
18. Emini, E., Nara, P., Schleif, W., Lewis, J., Davide, J., Lee, D., Kessler, J., Conley, S., Matsusshita, S., Putney, S., Gerety, R. and Eichberg, J. Antibody mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees. Journal of Virology 1990, 64, 3674-3678.
19. Matsushita, S., Robert-Guroff, M., Rusche, J., Koito, A., Hattori, T., Javaherian, K., Takatsuki, K. and Putney, S. Characterization of a Human Immunodeficiency Virus neutralizing monoclonal antibody and mapping of the neutralizing epitope. Journal of Virology 1988, 62, 2107-2114.
20. Skinner, M., Ting, R., Langlois, A., Weinhold, K., Lyerly, H., Jahaverian, K. and Mathews, T.J. Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein. AIDS Research on Human Retroviruses 1989, 4, 187-197.
21. Pal, R., di Marzo Veronese, F., Nair, B., Rahman, R., Hoke, G., Mumbauer, S. and Sarngadharan, M. Characterization of a neutralizing monoclonal antibody to the external glycoprotein of HIV-1. Intervirology 1992, 86, 86-93.
22. Liou, R.S., Rosen, E., Fung, M., Sun, W., Sun, C., Gordon, W., Chang, N. and Chang, T. A chimeric mouse-human antibody that retains specificity for HIV gp120 and mediates the lysis of HIV-infected cells. Journal of Immunology 1989, 143, 3967-3975.
23. Duarte, C., Montero, M., Seralena, A., Valdés, R., Jiménez, V., Benítez, J., Narciandi, E., Madrazo, J., Padrón, G., Sénchez, G., Girlund, G., Pearson, K., Domínguez, M., Wharen, B. and Menéndez, A. Multi-epitope polypeptide containing epitopes of HIV-1 envelope induces neutralizing monoclonal antibodies against V3 loop. AIDS Research on Human Retroviruses 1994, 10, 235.
24. Scott, C.F., Silver, S., Profy, A., Putney, S., Langlois, A., Weinhold, K. and Robinson, J. Human monoclonal antibody that recognized the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type III MN strain. Proceedings of the National Academy of Sciences of the United States of America 1990, 8, 8596-8601.
25. Durda, P., Bacheler, L., Clapham, P., Jenoski, A., Leece, B., Matthews, T., McKnight, A., Pomerantz, R., Rayner, M. and Weinhold, K. HIV-1 neutralizing monoclonal antibodies induced by a synthetic peptide. AIDS Research on Human Retroviruses 1990, 6, 1115-1213.
26. Ohno, T., Terada, M., Yoneda, Y., Shea, K., Chambers, R., Stroka, D., Nakamura, M. and Kufe, D. A broadly neutralizing antibody that recognizes the V3 region of human immunodeficiency virus type 1 glycoprotein gp120. Proceedings of the National Academy of Sciences of the United States of America 1991, 88, 10726-10729.
27. Buchbinder, A., Karwowska, S., Gorny, M., Burda, S. and Zolla-Pazner, S. Synergy between human monoclonal antibodies to HIV extends their effective biologic activity against homologous and divergent strains. AIDS Research on Human Retroviruses 1992, 8, 425-427.
28. Whitte-Scharf, M.E., Potts, B., Smith, L., Sokolowski, K., Rusche, J. and Silver, S. Broadly neutralizing monoclonal antibodies to the V3 region of HIV-1 can be elicited by peptide immunization. Virology 1993, 192, 197-206.
29. Palker, T., Matthews, T., Langloise, A., Tanner, M., Martin, M., Scearce, R., Kim, J., Berzofski, J., Bolognesi, D. and Haynes, B. Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes. Journal of Immunology 1989, 142, 3612-3619.
30. Neurath, R., Jiang, S., Strick, N., Kolbe, H., Kieny, M.P., Muchmore, E. and Girard, M. Antibody responses of chimpanzees immunized with synthetic peptides corresponding to full length V3 hypervariable loops of HIV-1 envelope glycoproteins. AIDS Research on Human Retroviruses 1991, 7, 813-823.
31. Javaherian, K., Langlois, A., LaRosa, G., Profy, A., Bolognesi, D., Herlihy, W., Putney, S. and Mathews, T. Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1. Science 1990, 250, 1590.
32. Jiménez, V., Guimil, R., Ubieta, R., Ochagavia, M., Silva, A., Villegas, G. and Herrera, L. Sintesis químico-enzimática del gen de la proinsulina humana. Biotecnología Aplicada 1990, 7, 142-152.
33. Sambrook, J., Fritsch, E.F. and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1989.
34. Castellanos, L., Ubieta, R., Hardy, E., Pérez, G., Santiago, N., Gonzalez, M., Fernández, C., Jiménez, V., Estrada, R., Silva, A. and Herrera, L. Expression of IL-2 proinsulin fusion protein. Folding of the fusion protein and conversion into insulin by one step removal of C-peptide and leader sequence. Protein Engineering 1993, 6, (S), 9.
35. Sanger, F., Nicklen, S. and Coulson, A.R. DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences of the United States of America 1977, 74, 5463-5467.
36. Laemli, U.K. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 1970, 227, 680-685.
37. Houghten, R.A. General method for the rapid synthesis of large number of peptides. Specificity of antigen antibody interaction at the level of individual amino acids. Proceedings of the National Academy of Sciences of the United States of America 1985, 82, 5131.
38. Akerblom, L., Hinkula, J., Broliden, P., Mäkitalo, H., Fridbrger, T., Rosen, J., Eriksson, M.V., Morein, B. and Wahren, B. Neutralizing monoclonal antibodies to HIV-1 gp120. AIDS 1990, 4, 953-960.
39. Bradford, M.B. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Annals of Biochemistry and Experimental Medicine 1976, 72, 248-254.
40. La Rosa, G.J., Davide, J.P., Weinhold, K., Waterbury, J., Profy, A.T., Lewis, J.A., Langlois, A.J., Dreesman, G.R., Boswell, R.N., Shadduck, P., Holley, L.H., Karplus, M., Bolognesi, D.P., Matthews, T,J., Emini, E.A. and Putney, S.D. Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science 1990, 249, 932-935.
41. Myers, G., Korber, B., Wain-Hobson, S., Smith, R. and Pavlakis, G.N. (Eds) Human Retroviruses and AIDS. A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Theoretical Biology and Biophysics Group T-10, Los Alamos National Laboratory, Los Alamos, NM, 1994.
42. Putney, S., LaRosa, G., Profy, A., Silver, S., Scott, C., Javaherian, K., et al. HIV-1 principal neutralization determinant elicits broadly neutralizing antibodies. In Vaccines '91, eds Brown, F., Chanock, R.M. and Lerner, R.A. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1991.
43. Lake, F., Kawamura, T., Tomiyama, T., Robinson, W.E., Matsumoto, Y., Masuno, Y. and Hersh, E. Generation and characterization of a human monoclonal antibody that neutralizes diverse HIV-1 isolates in vitro. AIDS 1992, 6, 17-24.
44. Gorny, M., Conley, A., Karwoska, S., Buchbinder, A., Xu, J., Emini, E., Koening, S. and Zolla-Pazner, S. Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody. Journal of Virology 1992, 66, 7538-7542.
45. R vaccine: the advantages of controlled release microparticles. In Retroviruses of Human AIDS and Related Animal Diseases. 8th Colloque des 'Cent Gardes', 25-27 October 1993, eds Girard, M. and Valeette, L. Foundation Marcel Merieux, Marnes-La-Coquette, Paris, 1994, pp. 309-313.
46. Haynes, B., Torres, J.V., Langlois, A.J., Bolognesi, D.P., Gardner, M.B., Palker, T.J., Scearce, R.M., Jones, D.M., Moody, M.A., McDanal, C. and Matthews, T.J. Induction of HIVMN neutralizing antibodies in primates using a primeboost regimen of hybrid synthetic gp120 envelope peptides. Journal of Immunology 1993, 151, 1646-1653.
47. Warren, R., Wolf, H., Stunz, G. and Kennedy, R. Antibody reactivity to synthetic peptides representing the principal neutralizing determinant of HIV-1 in mouse strain following repeated immunization with recombinant gp160. Experimental and Clinical Immunogenetics 1993, 10, 168-175.
48. Laman, J., Schellekens, M., Abacioglu, Y., Lewis, G., Tersmette, M., Fouchier, R., Langedijk, J., Claassen, E. and Boersma, W. Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain. Journal of Virology 1992, 66, 1823-1831.
49. Belshe, R.B., Graham, M.S. and Keefer, M.C. et al. Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. Journal of the American Medical Association 1994, 272, 475-480.
50. Excler, J., Salmon, D., Pialoux, G., et al. Combined antigen regimes for vaccination against HIV-1. In Retroviruses of Human AIDS and Related Animal Diseases. 8th Colloque des 'Cent Gardes', 25-27 October 1993, eds Girard, M. and Valeette, L. Foundation Marcel Merieux, Marnes-La-Coquette, Paris, 1994, pp. 281-284.
51. Pialoux, G., Excler, J.L., Riviere, Y., Gonzalez-Canali, G., Feuillie, V., Coulaud, P., Gluckman, J., Matthews, T., Meignier, B., Kieny, M.P., Gonnet, P., Diaz, I., Meric, C., Paoletti, E., Tartaglia, J., Salomon, H. and Plotkin, S. The Agis Group and L'Agence Nationale de Recherche sur le SIDA. A prime boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing gp160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). AIDS Research on Human Retroviruses 1995, 11, 373-381.
52. Golding, H., D'Souza, P., Bradac, J., Mathieson, B. and Fast, P. Neutralization of HIV-1. AIDS Research on Human Retroviruses 1994, 10, (6), 633-643.
53. Francis, D., Fast, P., Harkonen, S., McElrath, M., Belshe, R., Berman, P., Gregory, T. and the AIDS Vaccine Evaluation Group. MN rgp120 (Genentech) vaccine safe and immunogenic - But will it protect humans? In 10th International Conference on AIDS, Yokohama, Japan. Abstract No. 314A, Vol. 1, 1994, p. 90.
54. Graham, B.S. Serological responses to candidate AIDS vaccines. AIDS Research on Human Retroviruses 1994, 10, (2), S145-S148.
55. Duarte, C.A., Pérez, L., Vázquez, J., Dueñas, M., Vilarrubia, D.L., Navea, L., Valdés, R., Reyes, O., Ayala, M. and Gavilondo, J. Epitope mapping, V-region DNA sequence, and neutralizing Fab fragments of two monoclonal antibodies against the HIV-1 V3 loop. Immunotechnology 1996, 2, 11-20.